Estimated glomerular filtration rate and the risk of stroke in individuals with diabetes mellitus and atrial fibrillation insight from a large contemporary population study

Wang TJ et al (2003) A risk score for Predicting Stroke or Death in individuals with New-Onset Atrial Fibrillation in the community: the Framingham Heart Study. J Am Med Assoc 290:1049–1056

Article  Google Scholar 

Hart RG et al (2007) Independent predictors of Stroke in patients with atrial fibrillation: a systematic review. Neurology 69:546–554

Article  Google Scholar 

Gage BF et al (2001) Validation of clinical classification schemes for predicting Stroke: results from the National Registry of Atrial Fibrillation. J Am Med Assoc 285:2864–2870

Article  CAS  Google Scholar 

Lip GYH et al (2010) Refining clinical risk stratification for predicting Stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 137:263–272

Article  PubMed  Google Scholar 

Kirchhof P et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal vol. 37 Preprint at https://doi.org/10.1093/eurheartj/ehw210

January CT, AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation (2019) : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation vol. 140 e125–e151 Preprint at https://doi.org/10.1161/CIR.0000000000000665 (2019)

Piccini JP et al (2013) Renal dysfunction as a predictor of Stroke and systemic Embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF. Circulation 127:224–232

Article  CAS  PubMed  Google Scholar 

Singer DE et al (2013) A new risk scheme to predict ischemic Stroke and other thromboembolism in atrial fibrillation: the ATRIA study Stroke risk score. J Am Heart Assoc. https://doi.org/10.1161/JAHA.113.000250

Article  PubMed  PubMed Central  Google Scholar 

Olesen JB et al (2012) Stroke and bleeding in Atrial Fibrillation with chronic Kidney Disease. N Engl J Med 367:625–635

Article  CAS  PubMed  Google Scholar 

Go AS et al (2009) Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 119:1363–1369

Article  PubMed  PubMed Central  Google Scholar 

Nakayama M et al (2007) Kidney dysfunction as a risk factor for first symptomatic Stroke events in a general Japanese population - the Ohasama study. Nephrol Dialysis Transplantation 22:1910–1915

Article  Google Scholar 

Hart RG, Pearce LA, Asinger RW, Herzog CA (2011) Warfarin in atrial fibrillation patients with moderate chronic Kidney Disease. Clin J Am Soc Nephrol 6:2599–2604

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeng WT et al (2015) Risk of thromboembolic events in atrial fibrillation with chronic Kidney Disease. Stroke. https://doi.org/10.1161/STROKEAHA.114.006881

Article  PubMed  Google Scholar 

Friberg L, Benson L, Lip GYH (2015) Balancing Stroke and bleeding risks in patients with atrial fibrillation and Renal Failure: the Swedish Atrial Fibrillation Cohort study. Eur Heart J 36:297–306

Article  PubMed  Google Scholar 

Banerjee A et al (2013) Renal impairment and ischemic Stroke risk assessment in patients with atrial fibrillation: the Loire valley atrial fibrillation project. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2013.02.035

Article  PubMed  Google Scholar 

Reges O et al (2020) Combining inpatient and outpatient data for diagnosis of non-valvular atrial fibrillation using electronic health records: a validation study. Clin Epidemiol 12:477–483

Article  PubMed  PubMed Central  Google Scholar 

Karpati T et al (2014) Towards a subsiding Diabetes epidemic: Trends from a large population-based study in Israel. Popul Health Metr. https://doi.org/10.1186/s12963-014-0032-y

Article  PubMed  PubMed Central  Google Scholar 

Schold JD et al (2011) Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol 6:497–504

Article  PubMed  PubMed Central  Google Scholar 

Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36:4391–4400

Article  PubMed  PubMed Central  Google Scholar 

Anderson JL et al (2013) Management of patients with atrial fibrillation (compilation of 2006 accf/aha/esc and 2011 accf/aha/hrs recommendations): a report of the American college of cardiology/american heart association task force on practice guidelines. Circulation 127:1916–1926

Article  Google Scholar 

Potpara TS, Ferro CJ, Lip GYH (2018) Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. Nat Rev Nephrol 14:337–351

Article  CAS  PubMed  Google Scholar 

Lemkes BA et al (2010) Hyperglycemia: a prothrombotic factor? J Thromb Haemostasis Preprint at. https://doi.org/10.1111/j.1538-7836.2010.03910.x

Article  Google Scholar 

Keller C, Katz R, Cushman M, Fried LF, Shlipak M (2008) Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the multi-ethnic study of Atherosclerosis (MESA). BMC Nephrol 9,

Grant PJ (2007) Diabetes Mellitus as a prothrombotic condition. J Intern Med 262:157–172

Article  CAS  PubMed  Google Scholar 

Molino D, De Lucia D, De Santo NG (2006) Coagulation disorders in uremia. Semin Nephrol. https://doi.org/10.1016/j.semnephrol.2005.06.011

Article  PubMed  Google Scholar 

Carr ME (2001) Diabetes Mellitus: a hypercoagulable state. J Diabetes Complications 15:44–54

Article  CAS  PubMed  Google Scholar 

Jalal DI, Chonchol M, Targher G (2010) Disorders of hemostasis associated with chronic kidney disease. Seminars in Thrombosis and Hemostasis vol. 36 34–40 Preprint at https://doi.org/10.1055/s-0030-1248722

Pretorius E (2017) Mechanisms of Hypercoagulation and Aberrant Clot Lyses in Type 2 Diabetes. in Mechanisms of Vascular Defects in Diabetes Mellitus 377–393 https://doi.org/10.1007/978-3-319-60324-7_17

Kuno T et al (2020) Oral anticoagulation for patients with Atrial Fibrillation on Long-Term Hemodialysis. J Am Coll Cardiol 75:273–285

Article  CAS  PubMed  Google Scholar 

Randhawa MS et al (2020) Association between Use of Warfarin for Atrial Fibrillation and outcomes among patients with end-stage renal Disease: a systematic review and Meta-analysis. JAMA Netw Open 3, e202175

Bansal N, Fan D, Hsu C, yuan, Ordonez JD, Go AS (2014) Incident atrial fibrillation and risk of death in adults with chronic Kidney Disease. J Am Heart Assoc 3,

HS H et al (2014) Clinical significance of chronic Kidney Disease and atrial fibrillation on morbidity and mortality in patients with acute Myocardial Infarction. Am J Nephrol 40:345–352

Article  Google Scholar 

Lau YC, Proietti M, Guiducci E, Blann AD, Lip GYH (2016) Atrial fibrillation and thromboembolism in patients with chronic Kidney Disease. J Am Coll Cardiol 68:1452–1464

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif